Sheffer v. Novartis Pharmaceuticals Corporation, 873 F. Supp. 2d 371

Sheffers reside in Yorkshire, Ohio, within the Southern District of Ohio; all events and claims arise there.
Novartis markets and distributes Aredia nationwide, including Ohio.
Ms. Sheffer received Aredia treatment in Ohio for breast cancer, allegedly causing osteonecrosis of the jaw.
Plaintiffs asserted multiple theories, including strict liability and failure to warn, seeking damages; diversity jurisdiction was invoked.
The case was transferred to MDL-1760 in the Middle District of Tennessee and later remanded back to the District of Columbia for venue consideration.

Issue	Plaintiff's Argument	Defendant's Argument	Held
Whether § 1404(a) transfer is proper.	Sheffer choice of forum should be respected.	Transfer to Ohio serves convenience and justice.	Transfer proper; factors favor transfer.
Private-interest factors favoring transfer.	Plaintiff’s forum is proper and convenient.	Ohio ties and events in Ohio predominate.	Most private factors neutral or favor transfer; plaintiff's forum choice weighs against transfer.
Where the claim arose.	Injury in Ohio; DC is not forum of injury.	Claim arose where drug was administered (Ohio).	Favors transfer to Ohio.
Convenience of witnesses.	Non-party witnesses primarily in Ohio; live testimony feasible in DC via deposition.	Non-resident witnesses may be unavailable in DC.	Favors transfer; issues lack detailed showing of witness unavailability.
Public-interest considerations.	DC familiarity with federal law and statutes of limitations.	Ohio familiarity with Ohio tort law and local interest.	Public factors favor transfer to Ohio.

Van Dusen v. Barrack, 376 U.S. 612 (U.S. 1964) (venue transfer under §1404(a) is a matter of judicial housekeeping with case-by-case discretion)
Trout Unlimited v. U.S. Dep’t of Agric., 944 F. Supp. 13 (D.D.C. 1996) (identifies private/public factors guiding transfer analysis)
Ferens v. John Deere Co., 494 U.S. 516 (U.S. 1990) (applies choice-of-law considerations in transfer)